Full Text View
Tabular View
No Study Results Posted
Related Studies
Body Water Content in Cyanotic Congenital Heart Disease
This study has been completed.
Study NCT00000107   Information provided by National Center for Research Resources (NCRR)
First Received: January 18, 2000   Last Updated: June 23, 2005   History of Changes

January 18, 2000
June 23, 2005
 
 
 
 
Complete list of historical versions of study NCT00000107 on ClinicalTrials.gov Archive Site
 
 
 
Body Water Content in Cyanotic Congenital Heart Disease
 

Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.

 
 
Observational
Natural History, Case Control
Heart Defects, Congenital
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
 
 

Inclusion Criteria:

  • Resting blood pressure below 140/90
Both
17 Years to 60 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000107
 
NCRR-M01RR00109-0737, M01RR00109
National Center for Research Resources (NCRR)
 
 
National Center for Research Resources (NCRR)
December 2003

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP